Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque

NCT00760786 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Intensive lipid lowering plus Omega3-fatty acid
DRUG: Moderate lipid lowering plus Omega3-fatty acid
DRUG: Intensive lipid lowering plus placebo
DRUG: Moderate lipid lowering plus placebo

Sponsor

Samsung Medical Center